Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

yttrium Y 90 DOTA monoclonal antibody HuAFP31

Known as: Yttrium Y-90 Tacatuzumab Tetraxetan, Yttrium Y 90 Tacatuzumab Tetraxetan, Y90 DOTA MOAB HuAFP31 
A radioimmunoconjugate comprised of the humanized monoclonal antibody tacatuzumab, directed against alpha fetoprotein, that is conjugated to the… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The aim of this study was to assess the early therapy response in patients with unresectable CCA who received Y-90 microsphere… Expand
  • table 2
  • table 1
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2019
2019
Purpose: Radiolabeled somatostatin receptor 2 (SSTR2) antagonists have shown higher tumor uptake and tumor-to-organ ratios than… Expand
  • figure 1
  • table 2
  • table 1
  • figure 2
  • table 3
Is this relevant?
Review
2018
Review
2018
Nuclear theranostics functions as a bridge which connects targeted diagnosis to targeted therapy, just like Turkey functions as a… Expand
  • figure 1
Is this relevant?
Review
2016
Review
2016
Intra-arterial radionuclide therapies serve essentially as internal radiation treatment options for both primary and metastatic… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2014
Review
2014
PURPOSE The purpose of this presentation is to discuss the radiation safety and dosimetric technique used for the therapeutic… Expand
Is this relevant?
2013
2013
The biodistribution of the anti-CD37 radioimmunoconjugate 177Lu-tetraxetan-tetulomab (177Lu-DOTA-HH1) was evaluated… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2013
2013
Objective: Hepatic artery perfusion scintigraphy is a routine procedure for patient evaluation before Y-90 radiomicrosphere… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2009
2009
Pancreatic cancer is a silent disease that most commonly presents in an already metastatic form. Current treatment options… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2009
2009
The use of selective internal radiation therapy for treatment of hepatocellular carcinoma and liver metastases using Y-90 labeled… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?